Replacing the Combined Test by Cell-Free DNA Testing in Screening for Trisomies 21, 18 and 13: Impact on the Diagnosis of Other Chromosomal Abnormalities

Publisher： Karger

E-ISSN： 1421-9964|35|3|174-184

ISSN： 1015-3837

Source： Fetal Diagnosis and Therapy, Vol.35, Iss.3, 2014-02, pp. : 174-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

First-Trimester Contingent Screening for Trisomies 21, 18 and 13 by Biomarkers and Maternal Blood Cell-Free DNA Testing

By  

Fetal Diagnosis and Therapy, Vol. 35, Iss. 3, 2013-10 ,pp. : 185-192

Karger

Access to resources Recommend Favorite

First-Trimester Screening for Trisomies 21, 18 and 13 by Ultrasound and Biochemical Testing

By  

Fetal Diagnosis and Therapy, Vol. 35, Iss. 2, 2013-12 ,pp. : 118-126

Karger

Access to resources Recommend Favorite

Differential Effect of Advanced Maternal Age on Prenatal Diagnosis of Trisomies 13, 18 and 21

By  

Fetal Diagnosis and Therapy, Vol. 14, Iss. 3, 1999-06 ,pp. : 181-184

Karger

Access to resources Recommend Favorite

Impact of Quality of Nuchal Translucency Measurements on Detection Rates of Trisomies 13 and 18

By  

Fetal Diagnosis and Therapy, Vol. 27, Iss. 2, 2010-03 ,pp. : 68-71

Karger

Access to resources Recommend Favorite

Analysis of Cell-Free DNA in Maternal Blood in Screening for Aneuploidies: Meta-Analysis

By  

Fetal Diagnosis and Therapy, Vol. 35, Iss. 3, 2014-02 ,pp. : 156-173

Karger

Access to resources Recommend Favorite